Regarding Rogers MS, Yuen PM, Wong S. Avoiding manual removal of placenta: Evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet Gynecol. 2007;86:48-54 [1]

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 6, 2007, Pages 764-

  Van Stralen, G ^a   Van Roosmalen, J ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; UTEROTONIC AGENT;

BLEEDING; HUMAN; LETTER; OPERATION DURATION; PRIORITY JOURNAL; RETAINED PLACENTA; TECHNIQUE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; FEMALE; HUMANS; MISOPROSTOL; OXYTOCICS; PLACENTA, RETAINED; PREGNANCY;

EID: 34249056855     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701330054     Document Type: Letter

References (3)

1. Weeks AD, Mirembe FM. The retained placenta - new insights into an old problem. Eur J Obstet Gynecol Reprod Biol. 2002;102:109-10.
2. Chong YS, Chua S, Shen L, Arulkumaran S. Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery. Eur J Obstet Gynecol Reprod Biol. 2004;113:191-8.
3. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90:88-92.